This content is machine translated Atherosclerotic Coronary Plaques in High-Risk Patients Who benefits from preventive PCI? For patients with ASCVD, modern imaging techniques such as CCTA and cardiac MRI often provide a solid basis for subsequent treatment decisions. The invasive cardiac catheterization procedure is currently used...…
View Post 12 min This content is machine translated Cardiology and Nutrition Ultra-Processed Foods and Cardiovascular Risk—The New AHA Position Ultra-processed foods (UPFs ) account for a significant portion of energy intake in Western countries—in the United States, an estimated more than half. Given this ubiquity and a growing number...…
View Post 11 min This content is machine translated Cardiometabolism Retatrutid and the TRIUMPH Program: The Triple Agonist on the Horizon Incretin-based obesity therapy has advanced rapidly in just a few years: from GLP-1 receptor agonists (semaglutide) to the dual GIP/GLP-1 agonist tirzepatide and on to a triple agonist. Retatrutide (LY3437943)...…
View Post 12 min This content is machine translated Hepatology and Metabolism The Mediterranean Diet for MASLD/MASH—What the EASL-EASD-EASO Guidelines Specifically Recommend Since an international Delphi consensus in 2023, the condition formerly known as nonalcoholic fatty liver disease (NAFLD) has been called MASLD— “metabolic dysfunction-associated steatotic liver disease.” It is defined as...…
View Post 9 min This content is machine translated Cardiology Minimally invasive – the quiet triumph of modern heart surgery The median sternotomy was the standard approach for cardiac surgery for many decades. With the advent of minimally invasive procedures, the guiding question of cardiac surgery shifted: away from maximum...… CME-Test
View Post 4 min This content is machine translated Hypertension: the most important facts for daily practice Early dual antihypertensive therapy is usually indicated 95% of all hypertensive patients have primary hypertension. Over the years, the classification has evolved into a more differentiated system. The current ESC guideline, for example, differentiates between hypertension, raised...…
View Post 7 min This content is machine translated Disease-modifying therapies for ATTR-CM TTR stabilizers, gene silencing and gene scissors: where do we stand? Advances in the understanding of the pathophysiology of transthyretin amyloid cardiomyopathy (ATTR-CM) have revolutionized the therapeutic landscape in recent years. TTR stabilizers such as tafamidis and acoramidis can reduce TTR...…
View Post 11 min This content is machine translated Type 2 diabetes: cardiovascular risk reduction is realistic Modern active ingredients and lifestyle – every step counts Although diabetics have an increased risk of developing cardiovascular diseases such as myocardial infarction, heart failure or stroke, scientific data suggests that protective effects can be achieved through the best...…
View Post 12 min This content is machine translated Treatable risk factor Depression and cardiovascular mortality New meta-analyses, the first ESC consensus document on mental health and heart disease and groundbreaking Lancet dataon antidepressant drugs show: Depression is an independent, quantifiable and treatable risk factor for...…
View Post 6 min This content is machine translated Hypertrophic cardiomyopathies (HCM) How do myosin inhibitors perform in different HCM phenotypes? Cardiac myosin inhibitors have been developed as a targeted therapeutic option for modulating sarcomere function. While in clinical trials in obstructive hypertrophic cardiomyopathy they brought about a greater improvement in...…
View Post 15 min This content is machine translated Cardiovascular health in women Hormonal contraception, stress disorders and cardiovascular risk in women Cardiovascular disease is the leading cause of death in women, and stress-related psychiatric disorders are considered cardiovascular risk factors in their own right. Hormonal contraceptives, which are used by around...…
